Scientific Reports (Jun 2020)

Serum hepcidin level, iron metabolism and osteoporosis in patients with rheumatoid arthritis

  • Hiroe Sato,
  • Chinatsu Takai,
  • Junichiro James Kazama,
  • Ayako Wakamatsu,
  • Eriko Hasegawa,
  • Daisuke Kobayashi,
  • Naoki Kondo,
  • Takeshi Nakatsue,
  • Asami Abe,
  • Satoshi Ito,
  • Hajime Ishikawa,
  • Takeshi Kuroda,
  • Yoshiki Suzuki,
  • Ichiei Narita

DOI
https://doi.org/10.1038/s41598-020-66945-3
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 12

Abstract

Read online

Abstract Hepcidin, a major regulator of iron metabolism and homeostasis, is regulated by inflammation. Recent studies have suggested that hepcidin and iron metabolism are involved in osteoporosis, and the aim of this study was to determine whether serum hepcidin levels are correlated with the degree of osteoporosis in patients with rheumatoid arthritis (RA). A total of 262 patients with RA (67.5 ± 11.4 years; 77.5% female) were enrolled. Serum iron, ferritin, and hepcidin levels were positively correlated each other. Multiple regression analyses revealed that the serum iron level was positively correlated with femoral T and Z scores, whereas the serum hepcidin level was not. Serum hepcidin level was correlated with the serum 25-hydroxy vitamin D level, which was in turn positively related to the femoral Z score. Serum hepcidin and serum iron were indirectly and directly related to osteoporosis in patients with RA.